Cesar G. F.
- Country
- Spain
- Department
- Traumatology
Research Overview
- Evaluation of SAR442501 for Safety, Tolerability, Pharmacokinetics, and Efficacy in Pediatric Achondroplasia: A Phase 2, Open-Label, Dose Escalation Study
- Efficacy and Safety of Autologous Adipose-Derived Stem Cells (NVD003) Versus Iliac Crest Bone Graft in Pediatric Congenital Pseudarthrosis of the Tibia
Data & Insights
Has run more than one trial at 1 of 9 partner sites.
Specializations
Pediatric Growth Disorders
This investigator specializes in studying osteochondrodysplasia, with particular emphasis on achondroplasia in pediatric populations. Their research encompasses developmental bone disorders and skeletal growth conditions that affect children.
- Skeletal Development Disorders
- Growth Pattern Analysis
- Pediatric Bone Conditions
The investigator focuses on evaluating therapeutic interventions for skeletal growth disorders.
Clinical Pharmacology
Their expertise extends to studying pharmacokinetics and pharmacodynamics of novel therapeutic agents, particularly in pediatric applications. The research involves evaluating medication safety and effectiveness in young patients.
- Drug Safety Assessment
- Therapeutic Monitoring
- Pediatric Drug Development
Special attention is given to subcutaneous administration methods in pediatric treatments.
Therapeutic Development
The investigator's work involves assessing innovative treatments for genetic growth disorders. Their research aims to evaluate new therapeutic approaches for managing developmental skeletal conditions.
- Treatment Safety Evaluation
- Clinical Efficacy Assessment
- Pediatric Treatment Protocols
Focus areas include tolerability assessment and long-term therapeutic outcomes in pediatric patients.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.